| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |